Ibuprofeno Kabi

Ibuprofen, the active ingredient in Ibuprofeno Kabi, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an intravenous solution for intravenous use. It treats pain, fever and inflammation in adult patients requiring parenteral therapy.

GNH USA supplies Ibuprofeno Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofeno Kabi (ibuprofen) is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes.

- Pain: provides analgesia for acute moderate to severe pain when oral intake is not feasible. - Fever: lowers elevated body temperature in febrile patients. - Inflammation: diminishes inflammatory swelling in postoperative or trauma‑related conditions.

Adverse reactions may occur with any NSAID, including ibuprofen administered intravenously.

Common Side Effects: - Nausea - Dyspepsia - Headache - Injection site pain

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Acute renal failure - Severe hypersensitivity reactions such as anaphylaxis

When using Ibuprofeno Kabi, clinicians should consider several safety measures.

- Renal function: assess baseline renal status and monitor during therapy. - Gastrointestinal risk: avoid in patients with active ulcer disease or a history of GI bleeding. - Hypersensitivity: do not administer to individuals with known NSAID allergy. - Pregnancy: use only if the potential benefit outweighs the risk, as safety data are limited. - Concomitant medications: review for drugs that may increase bleeding or renal risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ibuprofeno Kabi can interact with several drug classes; careful assessment is required.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs: additive gastrointestinal and renal toxicity. - Lithium: ibuprofen may raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion. - Corticosteroids: heightened risk of gastrointestinal ulceration.